These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21750289)

  • 21. Effects of medical therapies on retinopathy progression in type 2 diabetes.
    Egan A; Byrne M
    Ir Med J; 2011 Feb; 104(2):37. PubMed ID: 21465870
    [No Abstract]   [Full Text] [Related]  

  • 22. Demographic characteristics and opioid prescribing.
    Maserejian NN; McKinlay JB
    JAMA; 2008 Apr; 299(15):1773; author reply 1774. PubMed ID: 18413872
    [No Abstract]   [Full Text] [Related]  

  • 23. Retinopathy progression in type 2 diabetes.
    Liew G; Wang JJ; Mitchell P
    N Engl J Med; 2010 Nov; 363(22):2171-2; author reply 2173-4. PubMed ID: 21105809
    [No Abstract]   [Full Text] [Related]  

  • 24. [Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances].
    Brath H; Wascher TC; Kästenbauer T; Toplak H
    MMW Fortschr Med; 2012 Jun; 154 Suppl 2():41-7. PubMed ID: 23424754
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variation in use of broad-spectrum antibiotics for acute respiratory tract infection.
    Mainous AG; Hueston WJ
    JAMA; 2003 Jun; 289(21):2797; author reply 2797-8. PubMed ID: 12783910
    [No Abstract]   [Full Text] [Related]  

  • 26. [Field, a randomized clinical trial of cardiovascular prevention with fenofibrate in type 2 diabetes].
    Radermecker RP; Scheen AJ
    Rev Med Liege; 2005 Dec; 60(12):957-61. PubMed ID: 16457397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Datapoints: prescription patterns for mood and anxiety disorders in a community sample.
    Mojtabai R
    Psychiatr Serv; 1999 Dec; 50(12):1557. PubMed ID: 10577871
    [No Abstract]   [Full Text] [Related]  

  • 28. [Part I. Fibrates in primary and secondary prevention].
    Clin Investig Arterioscler; 2016 Jul; 28 Suppl 3():3-10. PubMed ID: 27473465
    [No Abstract]   [Full Text] [Related]  

  • 29. The Microvascular and Macrovascular Benefits of Fibrates in Diabetes and the Metabolic Syndrome: A review.
    Malur P; Menezes A; DiNicolantonio JJ; O'Keefe JH; Lavie CJ
    Mo Med; 2017; 114(6):464-471. PubMed ID: 30228666
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quest of prescribing practice in Pakistan.
    Shiwani MH
    J Pak Med Assoc; 2006 May; 56(5):249-50. PubMed ID: 16767958
    [No Abstract]   [Full Text] [Related]  

  • 31. [The combinations of statins and fibrates: pharmacokinetic and clinical implications].
    González Santos P
    Clin Investig Arterioscler; 2014 Jul; 26 Suppl 1():7-11. PubMed ID: 25043540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combination therapy with statin and fibrate in patients with dyslipidemia associated with insulin resistance, metabolic syndrome and type 2 diabetes mellitus.
    Reyes-Soffer G; Rondon-Clavo C; Ginsberg HN
    Expert Opin Pharmacother; 2011 Jun; 12(9):1429-38. PubMed ID: 21426238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study].
    Ai M; Yoshida M
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():285-90. PubMed ID: 21661165
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiologists' approach to managing cardiovascular risk in patients with type 2 diabetes.
    Rocha N; Das SR
    J Diabetes; 2019 Jul; 11(7):605-609. PubMed ID: 31044534
    [No Abstract]   [Full Text] [Related]  

  • 35. Crisis in optometric screening of diabetic retinopathy: illusion or reality.
    Beaumont P; Madigan MC; Mathew RS
    Clin Exp Ophthalmol; 2011 Apr; 39(3):193-4. PubMed ID: 21489111
    [No Abstract]   [Full Text] [Related]  

  • 36. A piece of my mind. Slippery slopes and landing on your feet.
    Huesch MD
    JAMA; 2014 Mar; 311(12):1203-4. PubMed ID: 24668099
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial.
    Keech AC; Mitchell P; Summanen PA; O'Day J; Davis TM; Moffitt MS; Taskinen MR; Simes RJ; Tse D; Williamson E; Merrifield A; Laatikainen LT; d'Emden MC; Crimet DC; O'Connell RL; Colman PG;
    Lancet; 2007 Nov; 370(9600):1687-97. PubMed ID: 17988728
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New fibrate use and acute renal outcomes in elderly adults: a population-based study.
    Zhao YY; Weir MA; Manno M; Cordy P; Gomes T; Hackam DG; Juurlink DN; Mamdani M; Moist L; Parikh CR; Paterson JM; Wald R; Yao Z; Garg AX
    Ann Intern Med; 2012 Apr; 156(8):560-9. PubMed ID: 22508733
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of intravenous neuraminidase inhibitors during the 2009 pandemic: results from population-based surveillance.
    Fry AM; Pérez A; Finelli L
    JAMA; 2011 Jul; 306(2):160-2. PubMed ID: 21750292
    [No Abstract]   [Full Text] [Related]  

  • 40. Masters of complexity.
    Hickner J
    J Fam Pract; 2015 Dec; 64(12):761. PubMed ID: 26844992
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.